Biotech Reading List (May 2019)

Where Drugs Come From: A Comprehensive Look
Derek Lowe (In the Pipeline)
 
How pharmaceutical industry financial modelers think about your rare disease
Eric Vallabh Minikel (Cure FFI)
 
The antibiotics business is broken – but there’s a fix
Maryn McKenna (Wired)
 
Can We Afford to Be Cured? A Conversation With ICER’s Steve Pearson
Alex Lash (Xconomy)
 
How Biopharma Companies Use NIH and Vice Versa
Zachary Brennan (RAPS Regulatory Focus)
 
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy
Ben Fidler (Xconomy)
 
Doctors Propose New Diagnosis: ‘Unable to Pay for Prescriptions’
John Tozzi (Bloomberg)